The role of FDG‐PET/CT in suspected recurrence of breast cancer

Abstract

In patients with breast cancer and rising tumor markers, FDG-PET/CT had high performance indices and was superior to CT for diagnosis of tumor recurrence, which led to changes in the subsequent clinical management of 51% of these patients.